Search results for: Innovation Policy Prize
Filter search results
Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions
30 May 2017
…antibiotics. Participants offered a number of valuable insights into how further work could be approached in order to maximise both its practicality and its potential policy impact. These are summarised…
Professor Dame Sally Davies: Ten Years of the NIHR: Achievements and Challenges for the Next Decade
15 June 2017
In November 2016 Professor Dame Sally Davies delivered the 23rd OHE Annual Lecture on the topic of: Ten Years of the NIHR: Achievements and Challenges for the Next Decade. The…
OHE Lunchtime Seminar: How Cost-Effective are New Cancer Drugs in the U.S.?
2 August 2017
On Tuesday 19th September 2017, Professor Frank Lichtenberg from Columbia University will lead an OHE Lunchtime Seminar on the topic of: How cost-effective are new cancer drugs in the U.S.?…
Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market
12 December 2017
…(BIA) to provide important evidence for the ongoing policy analysis into the implications of the UK leaving the EU. It is published today to coincide with today’s House of Commons…
Seminar Briefing: The UK Biotech Sector and Brexit
1 May 2018
…Commentators and policymakers have expressed concern about the status of the biotech industry in the UK, as compared with the United States. In this Seminar Briefing, Owen and Hopkins outline…
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
What would be the price for an orphan drug that generate rates of return no greater/smaller than the industry average? Is it reasonable? The high cost of drugs for rare…
Opportunity Costs of New Health Care Technologies: A Research Agenda
8 August 2018
A new OHE Research Paper sets out an agenda for the development of methods to estimate cost-effectiveness thresholds in the NHS. For many years, health economists have been concerned with…
New Publication: Advanced Therapy Medicinal Products and Health Technology Assessment
12 October 2018
A new publication in the European Journal of Health Economics identifies potential challenges of ATMPs in view of current health technology assessment (HTA) methodology and explores potential solutions to these…
OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?
16 January 2020
…and pricing patterns. Some empirical examples will be discussed to illustrate these points. Dr Alistair McGuire is Professor of the Department of Health Policy at London School of Economics. Prior to…